Can early COVID-19 drugs keep high-risk patients out of the hospital?

NCT ID NCT04356495

Completed Disease control Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving early treatment to adults with COVID-19 who have risk factors (like age over 60 or high blood pressure) could prevent them from needing oxygen, hospitalization, or dying. About 412 people took part. The goal was to see if these treatments are safe and effective for use at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONA VIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19 Orthocoronavirinae infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONA VIRUS INFECTION SARS-COV2

Contacts and locations

Locations

Bordeaux university Hospital

Bordeaux, 33000, France
CHRU de Nancy

Nancy, France
CHU de Dijon-Bourgogne

Dijon, France
CHU de Montpellier

Montpellier, 34295, France
CHU de Toulouse

Toulouse, France
CNGE

Paris, France
Groupe hospitalier Paris Saint Joseph

Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.